Congestive Heart Failure in Dogs: Quality of Life Management

Congestive heart failure (CHF) in dogs requires active quality of life management alongside medication, as the condition causes exercise intolerance, respiratory difficulty, and progressive decline that affects every aspect of daily welfare.

Key Facts

Myxomatous mitral valve disease (MMVD) is the most common cause of CHF in dogs, particularly in Cavalier King Charles spaniels
Dilated cardiomyopathy (DCM) is common in large breeds including Dobermans, great Danes, and boxers
Preclinical heart disease (Stage B) can be detected years before CHF develops; EPIC trial results support starting pimobendan at Stage B2
Standard CHF treatment includes furosemide, pimobendan, and ACE inhibitors; spironolactone may be added as disease progresses
Dogs in CHF experience exercise intolerance, respiratory difficulty (particularly at rest in decompensated heart failure), and nocturnal coughing
Quality of life assessment in CHF dogs should evaluate willingness to engage in valued activities, comfort at rest, and respiratory effort
Dietary sodium restriction may be recommended in later-stage disease to reduce fluid retention
Median survival from onset of CHF with treatment is approximately 9-12 months, though this varies widely

Welfare Considerations

Congestive heart failure causes direct welfare harm through respiratory distress — dogs unable to breathe comfortably experience significant distress and anxiety. Acute decompensation with pulmonary oedema is a medical emergency that causes severe breathlessness. With appropriate medication, many dogs with CHF can maintain good quality of life for extended periods: exercise tolerance improves, coughing reduces, and dogs re-engage with valued activities. The welfare challenge is monitoring for decompensation before it causes acute crisis, and having honest conversations about quality of life decline when medication no longer controls symptoms. Home monitoring of resting respiratory rate is a simple, validated welfare monitoring tool that allows owners to detect early decompensation and seek adjustment of treatment before the dog experiences severe distress.

What You Can Do

Monitor your CHF dog's resting respiratory rate daily — rates above 30 breaths per minute warrant veterinary contact
Administer all prescribed medications consistently and attend all follow-up appointments for chest radiographs and monitoring
Modify exercise to your dog's capacity — short, gentle walks rather than enforced rest or strenuous activity
Discuss quality of life assessment tools and end-of-life planning with your vet early in the CHF management journey
Connect with breed-specific heart disease support communities for peer support and management resources